273
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings

(Research scholar) & (Assistant professor)
Pages 771-789 | Published online: 21 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Fahad S. Aldawsari, Osama H. Elshenawy, Mohamed A. M. El Gendy, Rodrigo Aguayo-Ortiz, Shairaz Baksh, Ayman O. S. El-Kadi & Carlos A. Velázquez-Martínez. (2015) Design and synthesis of resveratrol–salicylate hybrid derivatives as CYP1A1 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 30:6, pages 884-895.
Read now
Neha Gupta, Omar Al Ustwani, Li Shen & Roberto Pili. (2014) Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer. OncoTargets and Therapy 7, pages 223-234.
Read now

Articles from other publishers (17)

Usman Ali Ashfaq, Farah Shahid & Samman Munir. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes 29 72 .
Goutam Mukherjee, Prajwal P. Nandekar & Rebecca C. Wade. (2021) An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase. Communications Biology 4:1.
Crossref
Elizabeth Goya-Jorge, Rosa M. Giner, Maité Sylla-Iyarreta Veitía, Rafael Gozalbes & Stephen J. Barigye. (2020) Predictive modeling of aryl hydrocarbon receptor (AhR) agonism. Chemosphere 256, pages 127068.
Crossref
Alexander V. Dmitriev, Alexey A. Lagunin, Dmitry А. Karasev, Anastasia V. Rudik, Pavel V. Pogodin, Dmitry A. Filimonov & Vladimir V. Poroikov. (2019) Prediction of Drug-Drug Interactions Related to Inhibition or Induction of Drug-Metabolizing Enzymes. Current Topics in Medicinal Chemistry 19:5, pages 319-336.
Crossref
Rajni Sharma, Ibidapo S. Williams, Linda Gatchie, Vinay R. Sonawane, Bhabatosh Chaudhuri & Sandip B. Bharate. (2018) Furanoflavones pongapin and lanceolatin B blocks the cell cycle and induce senescence in CYP1A1-overexpressing breast cancer cells. Bioorganic & Medicinal Chemistry 26:23-24, pages 6076-6086.
Crossref
Dávid Pajtás, Krisztina Kónya, Attila Kiss-Szikszai, Petr Džubák, Zoltán Pethő, Zoltán Varga, György Panyi & Tamás Patonay. (2017) Optimization of the Synthesis of Flavone–Amino Acid and Flavone–Dipeptide Hybrids via Buchwald–Hartwig Reaction. The Journal of Organic Chemistry 82:9, pages 4578-4587.
Crossref
Siddharth S. Kesharwani, Prajwal P. Nandekar, Preeti Pragyan, Vijay Rathod & Abhay T. Sangamwar. (2016) Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations. Journal of Molecular Recognition 29:8, pages 370-390.
Crossref
Prajwal P. Nandekar, Kailas Khomane, Vikas Chaudhary, Vijay P. Rathod, Roshan M. Borkar, Murali Mohan Bhandi, R. Srinivas, Abhay T. Sangamwar, Sankar K. Guchhait & Arvind K. Bansal. (2016) Identification of leads for antiproliferative activity on MDA-MB-435 human breast cancer cells through pharmacophore and CYP1A1-mediated metabolism. European Journal of Medicinal Chemistry 115, pages 82-93.
Crossref
Krisztina Kónya, Dávid Pajtás, Attila Kiss-Szikszai & Tamás Patonay. (2015) Buchwald-Hartwig Reactions of Monohaloflavones. European Journal of Organic Chemistry 2015:4, pages 828-839.
Crossref
Preeti Pragyan, Siddharth S. Kesharwani, Prajwal P. Nandekar, Vijay Rathod & Abhay T. Sangamwar. (2014) Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations. Molecular Diversity 18:4, pages 865-878.
Crossref
Yan-Zhi Chen, Jing Li, Yu-Xia Zhao, Dan Liu, He-Tong Wang, Ya Gao & Ying Chen. (2014) RETRACTED ARTICLE: Genetic polymorphisms in the CYP1A1 and CYP1B1 genes and susceptibility to bladder cancer: a meta-analysis. Molecular Biology Reports 41:8, pages 4929-4940.
Crossref
Khaled M. Tumbi, Prajwal P. Nandekar, Naeem Shaikh, Siddharth S. Kesharwani & Abhay T. Sangamwar. (2014) Molecular dynamics simulation studies for DNA sequence recognition by reactive metabolites of anticancer compounds. Journal of Molecular Recognition 27:3, pages 138-150.
Crossref
Miroslav Pohanka. (2013) Role of oxidative stress in infectious diseases. A review. Folia Microbiologica 58:6, pages 503-513.
Crossref
Hanna Piotrowska, Malgorzata Kucinska & Marek Murias. (2013) Expression of CYP1A1, CYP1B1 and MnSOD in a panel of human cancer cell lines. Molecular and Cellular Biochemistry 383:1-2, pages 95-102.
Crossref
Prajwal P. Nandekar, Khaled M. Tumbi, Nitu Bansal, Vijay P. Rathod, Leena B. Labhsetwar, Neelagiri Soumya, Sushma Singh & Abhay T. Sangamwar. (2012) Chem-bioinformatics and in vitro approaches for candidate optimization: a case study of NSC745689 as a promising antitumor agent. Medicinal Chemistry Research 22:8, pages 3728-3742.
Crossref
Mariangellys Rodriguez & David A. Potter. (2013) CYP1A1 Regulates Breast Cancer Proliferation and Survival. Molecular Cancer Research 11:7, pages 780-792.
Crossref
Juan R Rodrigues, Jaime Charris, José Camacho, Arthur Barazarte, Neira Gamboa, Bianca Nitzsche, Michael Höpfner, Michael Lein, Klaus Jung & Claudia Abramjuk. (2013) N ′-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studies . Journal of Pharmacy and Pharmacology 65:3, pages 411-422.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.